Cited by 1,184Atrial Fibrillation Management and OutcomesVenous Thromboembolism Diagnosis and ManagementBlood Coagulation and Thrombosis Mechanisms

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation

Open access

Douketis, James D., Spyropoulos, Alex C., Kaatz, Scott, Becker, Richard C., Caprini, Joseph A., Dunn, Andrew S., Garcia, David A., Jacobson, Alan, Jaffer, Amir K., Kong, David F., Schulman, Sam, Turpie, Alexander G.G., Hasselblad, Vic, Ortel, Thomas L.·2015·New England Journal of Medicine

DOI 10.1056/nejmoa1501035PMC PMC4931686

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: It is uncertain whether bridging anticoagulation is necessary for patients with atrial fibrillation who need an interruption in warfarin treatment for an elective operation or other elective invasive procedure. We hypothesized that forgoing bridging anticoagulation would be noninferior to bridging with low-molecular-weight heparin for the prevention of perioperative arterial thromboembolism and would be superior to bridging with respect to major bleeding. METHODS: We performed a randomized, double-blind, placebo-controlled trial in which, after perioperative interruption of warfarin therapy, patients were randomly assigned to receive bridging anticoagulation therapy with low-molecular-weight heparin (100 IU of dalteparin per kilogram of body weight) or matching placebo administered subcutaneously twice daily, from 3 days before the procedure until 24 hours before the procedure and then for 5 to 10 days after the procedure. Warfarin treatment was stopped 5 days before the procedure and was resumed within 24 hours after the procedure. Follow-up of patients continued for 30 days after the procedure. The primary outcomes were arterial thromboembolism (stroke, systemic embolism, or transient ischemic attack) and major bleeding. RESULTS: In total, 1884 patients were enrolled, with 950 assigned to receive no bridging therapy and 934 assigned to receive bridging therapy. The incidence of arterial thromboembolism was 0.4% in the no-bridging group and 0.3% in the bridging group (risk difference, 0.1 percentage points; 95% confidence interval [CI], -0.6 to 0.8; P=0.01 for noninferiority). The incidence of major bleeding was 1.3% in the no-bridging group and 3.2% in the bridging group (relative risk, 0.41; 95% CI, 0.20 to 0.78; P=0.005 for superiority). CONCLUSIONS: In patients with atrial fibrillation who had warfarin treatment interrupted for an elective operation or other elective invasive procedure, forgoing bridging anticoagulation was noninferior to perioperative bridging with low-molecular-weight heparin for the prevention of arterial thromboembolism and decreased the risk of major bleeding. (Funded by the National Heart, Lung, and Blood Institute of the National Institutes of Health; BRIDGE ClinicalTrials.gov number, NCT00786474.).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa1501035

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215
Apixaban versus warfarin in patients with atrial fibrillation
Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943
Edoxaban versus warfarin in patients with atrial fibrillation
Giugliano, R. P., Ruff, C. T., Braunwald, E., Murphy, S. A., Wiviott, S. D., Halperin, J. L., Waldo, A. L., Ezekowitz, M. D., Weitz, J. I., Špinar, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1310907 · Cited by 5,164
Perioperative Management of Antithrombotic Therapy
Douketis, J. D., Spyropoulos, A. C., Spencer, F. A., Mayr, M., Jaffer, A. K., Eckman, M. H., Dunn, A. S., & Kunz, R. (2012) · CHEST Journal · doi:10.1378/chest.11-2298 · Cited by 1,658
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Kay, G. N., Huezey, J.-Y. L., Lowe, J. E., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.013 · Cited by 928
The Perioperative Management of Antithrombotic Therapy
Douketis, J. D., Berger, P. B., Dunn, A. S., Jaffer, A. K., Spyropoulos, A. C., Becker, R. C., & Ansell, J. (2008) · CHEST Journal · doi:10.1378/chest.08-0675 · Cited by 824
Management of Anticoagulation before and after Elective Surgery
Kearon, C., & Hirsh, J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705223362107 · Cited by 817
Cardiovascular, bleeding, and mortality risks in elderly medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation
Graham, D. J., Reichman, M. E., Wernecke, M., Zhang, R., Southworth, M. R., Levenson, M., Sheu, T.-C., Mott, K., Goulding, M. R., Houstoun, M., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.012061 · Cited by 644
Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation
Birnie, D. H., Healey, J. S., Wells, G. A., Verma, A., TANG, A. S. L., Krahn, A. D., Simpson, C. S., Paredes, F. A., Coutu, B., Leiria, T. L. L., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1302946 · Cited by 589
Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin
Healey, J. S., Eikelboom, J. W., Douketis, J. D., Wallentin, L. C., Oldgren, J., Yang, S., Themeles, E., Heidbüchel, H., Avezum, Á., Reilly, P. A., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.090464 · Cited by 540

Flagged first, then by citations

Show all 46 references

Research works printed but not linked: 1

10.1016/S0025-6196(11)60891-4 · DOI

Sorted by citations

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P. F., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castellà, M., Diener, H., Heidbüchel, H., Hendriks, J., et al. (2016) · EP Europace · doi:10.1093/europace/euw295 · Cited by 6,439
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418
“2%, respectively).(502) OAC interruptions should be minimized to prevent stroke.”
2021 ESC/EACTS Guidelines for the management of valvular heart disease
Vahanian, A., Beyersdorf, F., Praz, F., Milojevic, M., Baldus, S., Bauersachs, J., Capodanno, D., Conradi, L., De Bonis, M., De Paulis, R., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehab395 · Cited by 5,685
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000923 · Cited by 3,686
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Fleisher, L. A., Jneid, H. M., Mack, M. J., McLeod, C. J., O’Gara, P. T., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.03.011 · Cited by 3,380
“In patient groups other than those with mechanical heart valves, increasing concerns have surfaced that bridging therapy exposes patients to higher bleeding risks without reducing the risk of thromboembolism (199).”
Background
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A. M., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001193 · Cited by 3,072
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
January, C. T., Wann, L. S., Calkins, H., Chen, L. Y., Cigarroa, J. E., Cleveland, J. C., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., Furie, K. L., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000665 · Cited by 2,744
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Fleisher, L. A., Jneid, H. M., Mack, M. J., McLeod, C. J., O’Gara, P. T., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000503 · Cited by 2,544
“In patient groups other than those with mechanical heart valves, increasing concerns have surfaced that bridging therapy exposes patients to higher bleeding risks without reducing the risk of thromboembolism (199).”
Background
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
January, C. T., Wann, L. S., Calkins, H. G., Chen, L. Y., Cigarroa, J. E., Cleveland, J. C., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., Furie, K. L., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.01.011 · Cited by 2,252
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H. M., Krieger, E. V., Mack, M. J., McLeod, C., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.018 · Cited by 2,110
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
Steffel, J., Verhamme, P., Potpara, T. S., Albaladejo, P., Antz, M., Desteghe, L., Haeusler, K. G., Oldgren, J., Reinecke, H., Roldan-Schilling, V., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy136 · Cited by 2,123
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezw313 · Cited by 1,403
2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
Halvorsen, S., Mehilli, J., Cassese, S., Hall, T. S., Abdelhamid, M., Barbato, E., Hert, S. G. D., de Laval, I., Geisler, T., Hinterbuchner, L., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac270 · Cited by 1,287
2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation
Steffel, J., Collins, R., Antz, M., Cornu, P., Desteghe, L., Haeusler, K. G., Oldgren, J., Reinecke, H., Roldan-Schilling, V., Rowell, N., et al. (2021) · EP Europace · doi:10.1093/europace/euab065 · Cited by 1,132
Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation
Heidbüchel, H., Verhamme, P. B., Alings, M., Antz, M., Diener, H., Hacke, W., Oldgren, J., Sinnaeve, P., Camm, A. J., & Kirchhof, P. F. (2015) · EP Europace · doi:10.1093/europace/euv309 · Cited by 1,129
Editor's Choice – European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on the Management of Atherosclerotic Carotid and Vertebral Artery Disease
Naylor, R., Rantner, B., Ancetti, S., de Borst, G. J., Carlo, M. D., Halliday, A. W., Kakkos, S. K., Markus, H. S., McCabe, D. J. H., Sillesen, H. H., et al. (2022) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2022.04.011 · Cited by 999
Antithrombotic Therapy for Atrial Fibrillation
Lip, G. Y. H., Banerjee, A., Boriani, G., Chiang, C. E., Fargo, R. A., Freedman, B., Lane, D. A., Ruff, C. T., Turakhia, M. P., Werring, D. J., et al. (2018) · CHEST Journal · doi:10.1016/j.chest.2018.07.040 · Cited by 963
“The role of bridging has been tested in a randomized trial, Bridging Anticoagulation in Patients who Require Temporary Interruption of Warfarin Therapy for an Elective Invasive Procedure or Surgery (BRIDGE), performed in patients on warfarin who were candidates for an invasive procedure (patients with mechanical valve…”
BackgroundMethod
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy
Horlocker, T. T., Vandermeulen, E., Kopp, S. L., Gogarten, W., Leffert, L. R., & Benzon, H. T. (2018) · Regional Anesthesia & Pain Medicine · doi:10.1097/aap.0000000000000763 · Cited by 949
“A randomized, double-blind, placebo-controlled trial that compared dalteparin with placebo showed that there was no difference in the incidence of arterial thromboembolism between the 2 groups.(200) In addition, the incidence of major bleeding was 1.”
Background
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation
Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.08.017 · Cited by 933
Management of severe perioperative bleeding
Kozek‐Langenecker, S. A., Ahmed, A. B., Afshari, A., Albaladejo, P., Aldecoa, C., Barauskas, G., ROBERTIS, E. D., Faraoni, D., Filipescu, D. C., Fries, D. R., et al. (2017) · European Journal of Anaesthesiology · doi:10.1097/eja.0000000000000630 · Cited by 817
Editor's Choice – European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis
Kakkos, S. K., Gohel, M., Bækgaard, N., Bauersachs, R. M., Bellmunt-Montoya, S., Black, S. A., ten Cate‐Hoek, A. J., Elalamy, I., Enzmann, F., Geroulakos, G., et al. (2020) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2020.09.023 · Cited by 802
The management of antithrombotic agents for patients undergoing GI endoscopy
Acosta, R. D., Abraham, N. S., Chandrasekhara, V., Chathadi, K. V., Early, D. S., Eloubeidi, M. A., Evans, J. A., Faulx, A. L., Fisher, D. A., Fonkalsrud, L., et al. (2015) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2015.09.035 · Cited by 725
2021 ESC/EACTS Guidelines for the management of valvular heart disease
Beyersdorf, F., Vahanian, A. S., Milojevic, M., Praz, F., Baldus, S. E., Bauersachs, J. K., Capodanno, D., Conradi, L., Bonis, M. D., Paulis, R. D., et al. (2021) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezab389 · Cited by 653
Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions—Part II: Recommendations
Patel, I. J., Rahim, S., Davidson, J. C., Hanks, S. E., Tam, A. L., Walker, T. G., Wilkins, L. R., Sarode, R., & Weinberg, I. (2019) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2019.04.017 · Cited by 615
The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation
Andrade, J. G., Aguilar, M., Atzema, C. L., Bell, A., Cairns, J. A., Cheung, C. C., Cox, J. L., Dorian, P., Gladstone, D. J., Healey, J. S., et al. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.09.001 · Cited by 590
Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant
Douketis, J. D., Spyropoulos, A. C., Duncan, J. M., Carrier, M., Gal, G. L., Tafur, A. J., Vanassche, T., Verhamme, P. B., Shivakumar, S., Gross, P. L., et al. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.2431 · Cited by 538
2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery
Pagano, D., Milojevic, M., Meesters, M. I., Benedetto, U., Bolliger, D., von Heymann, C., Jeppsson, A., Koster, A., Osnabrugge, R. L. J., Ranucci, M., et al. (2017) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezx325 · Cited by 492
2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias
Cronin, E. M., Bogun, F. M., Maury, P., Peichl, P., Chen, M., Namboodiri, N., Aguinaga, L., Leite, L. R., Al‐Khatib, S. M., Anter, E., et al. (2019) · EP Europace · doi:10.1093/europace/euz132 · Cited by 479
2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery
Boer, C., Meesters, M. I., Milojevic, M., Benedetto, U., Bolliger, D., von Heymann, C., Jeppsson, A., Koster, A., Osnabrugge, R. L. J., Ranucci, M., et al. (2017) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2017.06.026 · Cited by 489
Perioperative Management of Antithrombotic Therapy
Douketis, J. D., Spyropoulos, A. C., Murad, M. H., Arcelus, J. I., Dager, W. E., Dunn, A. S., Fargo, R. A., Levy, J. H., Samama, C. M., Shah, S. H., et al. (2022) · CHEST Journal · doi:10.1016/j.chest.2022.07.025 · Cited by 494
2017 ACC Expert Consensus Decision Pathway for Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation
Doherty, J. U., Gluckman, T. J., Hucker, W. J., Januzzi, J. L., Ortel, T. L., Saxonhouse, S. J., & Spinler, S. A. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.11.024 · Cited by 449
2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias
Cronin, E. M., Bogun, F. M., Maury, P., Peichl, P., Chen, M., Namboodiri, N., Aguinaga, L., Leite, L. R., Al‐Khatib, S. M., Anter, E., et al. (2019) · Heart Rhythm · doi:10.1016/j.hrthm.2019.03.002 · Cited by 444
2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation
January, C. T., Wann, L. S., Calkins, H. G., Chen, L. Y., Cigarroa, J. E., Cleveland, J. C., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., Furie, K. L., et al. (2019) · Heart Rhythm · doi:10.1016/j.hrthm.2019.01.024 · Cited by 414
2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants
Tomaselli, G. F., Mahaffey, K. W., Cuker, A. C., Dobesh, P. P., Doherty, J. U., Eikelboom, J. W., Florido, R., Gluckman, T. J., Hucker, W. J., Mehran, R., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.04.053 · Cited by 420
2017 EACTS Guidelines on perioperative medication in adult cardiac surgery
Sousa‐Uva, M., Head, S. J., Milojevic, M., Collet, J., Landoni, G., Castellà, M., Dunning, J., Guðbjartsson, T., Linker, N., Sandoval, E., et al. (2017) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezx314 · Cited by 415
2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Thompson, A., Fleischmann, K. E., Smilowitz, N. R., Fuentes, L. D. L., Mukherjee, D., Aggarwal, N. R., Ahmad, F. S., Allen, R. B., Altin, S. E., Auerbach, A. D., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001285 · Cited by 435
2021 ESC/EACTS Guidelines for the management of valvular heart disease
Vahanian, A. S., Beyersdorf, F., Praz, F., Milojevic, M., Baldus, S. E., Bauersachs, J. K., Capodanno, D., Conradi, L., Bonis, M. D., Paulis, R. D., et al. (2022) · EuroIntervention · doi:10.4244/eij-e-21-00009 · Cited by 393
JCS/JSCS/JATS/JSVS 2020 Guidelines on the Management of Valvular Heart Disease
Izumi, C., Eishi, K., Ashihara, K., Arita, T., Otsuji, Y., Kunihara, T., Komiya, T., Shibata, T., Seo, Y., Daimon, M., et al. (2020) · Circulation Journal · doi:10.1253/circj.cj-20-0135 · Cited by 373
Interventional Spine and Pain Procedures in Patients on Antiplatelet and Anticoagulant Medications
Narouze, S., Benzon, H. T., Provenzano, D. A., Buvanendran, A., Andrés, J. A. D., Deer, T. R., Rauck, R. L., & Huntoon, M. A. (2015) · Regional Anesthesia & Pain Medicine · doi:10.1097/aap.0000000000000223 · Cited by 366
JCS 2020 Guideline Focused Update on Antithrombotic Therapy in Patients With Coronary Artery Disease
Nakamura, M., Kimura, K., Kimura, T., Ishihara, M., Otsuka, F., Kozuma, K., Kosuge, M., Shinke, T., Nakagawa, Y., Natsuaki, M., et al. (2020) · Circulation Journal · doi:10.1253/circj.cj-19-1109 · Cited by 359
Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
Kietaibl, S. A., Ahmed, A. B., Afshari, A., Albaladejo, P., Aldecoa, C., Barauskas, G., ROBERTIS, E. D., Faraoni, D., Filipescu, D. C., Fries, D. R., et al. (2023) · European Journal of Anaesthesiology · doi:10.1097/eja.0000000000001803 · Cited by 363
2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants
Tomaselli, G. F., Mahaffey, K. W., Cuker, A. C., Dobesh, P. P., Doherty, J. U., Eikelboom, J. W., Florido, R., Hucker, W. J., Mehran, R., Messe, S. R., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.09.1085 · Cited by 348
National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Diagnosis and Management of Atrial Fibrillation 2018
Brieger, D. B., Amerena, J. V., Attia, J., Bajorek, B. V., Chan, K. H., Connell, C., Freedman, B., Ferguson, C., Hall, T. L., Haqqani, H. M., et al. (2018) · Heart Lung and Circulation · doi:10.1016/j.hlc.2018.06.1043 · Cited by 335
“The Bridging Anticoagulation in Patients Who Require Temporary Interruption of Warfarin Therapy for an Elective Invasive Procedure or Surgery (BRIDGE) trial evaluated this strategy in AF patients receiving warfarin with at least one risk factor for stroke (but no recent stroke or TIA) undergoing non-cardiac surgical p…”
Diagnosis and management of acute lower gastrointestinal bleeding: guidelines from the British Society of Gastroenterology
Oakland, K., Chadwick, G., East, J. E., Guy, R., Humphries, A., Jairath, V., McPherson, S., Metzner, M., Morris, A. J., Murphy, M. F., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-317807 · Cited by 324
Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines
Veitch, A., Vanbiervliet, G., Gershlick, A., Boustière, C., Baglin, T. P., Smith, L., Radaelli, F., Knight, E., Gralnek, I. M., Hassan, C., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-311110 · Cited by 302
Perioperative Cardiovascular Risk Assessment and Management for Noncardiac Surgery
Smilowitz, N. R., & Berger, J. S. (2020) · JAMA · doi:10.1001/jama.2020.7840 · Cited by 288
2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation
Macle, L., Cairns, J. A., Leblanc, K., Tsang, T. S. M., Skanes, A. C., Cox, J. L., Healey, J. S., Bell, A., Pilote, L., Andrade, J. G., et al. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.07.591 · Cited by 275
2020 ACC/AHA guideline for the management of patients with valvular heart disease
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2021.04.002 · Cited by 279
Guidelines for Gastroenterological Endoscopy in Patients Undergoing Antithrombotic Treatment: 2017 Appendix on Anticoagulants Including Direct Oral Anticoagulants
Kato, M., Uedo, N., Hokimoto, S., Ieko, M., Higuchi, K., Murakami, K., & Fujimoto, K. (2018) · Digestive Endoscopy · doi:10.1111/den.13184 · Cited by 272
Atrial Fibrillation
Chung, M. K., Refaat, M. M., Shen, W.-K., Kutyifa, V., Cha, Y., Biase, L. D., Baranchuk, A. M., Lampert, R., Natale, A., Fisher, J. D., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.02.025 · Cited by 261
Management of Patients on Non–Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the American Heart Association
Raval, A. N., Cigarroa, J. E., Chung, M. K., Díaz‐Sandoval, L. J., Diercks, D., Piccini, J. P., Jung, H. S., Washam, J. B., Welch, B. G., Zazulia, A. R., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000477 · Cited by 251
Evidence based diagnosis and management of chronic subdural hematoma: A review of the literature
Mehta, V. A., Harward, S. C., Sankey, E. W., Nayar, G., & Codd, P. J. (2018) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2018.01.050 · Cited by 240
Peri‐operative management of anticoagulation and antiplatelet therapy
Keeling, D. M., Tait, R. C., & Watson, H. G. (2016) · British Journal of Haematology · doi:10.1111/bjh.14344 · Cited by 227
“There is now a randomized, double-blind, placebo-controlled trial of bridging in AF patients (Douketis et al , 2015).”
2020 Clinical guidelines for Atrial fibrillation and atrial flutter
Arakelyan, M. S., Bockeria, L. A., Vasilieva, E., Sp, G., Golukhova, E. Z., Gorev, M. V., Davtyan, K. V., Drapkina, O. M., Станиславовна, К. Е., Kuchinskaya, Е. А., et al. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-4594 · Cited by 258
Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines
Veitch, A., Vanbiervliet, G., Gershlick, A., Boustière, C., Baglin, T. P., Smith, L., Radaelli, F., Knight, E., Gralnek, I. M., Hassan, C., et al. (2016) · Endoscopy · doi:10.1055/s-0042-102652 · Cited by 224
2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery
Thompson, A., Fleischmann, K. E., Smilowitz, N. R., Fuentes, L. D. L., Mukherjee, D., Aggarwal, N. R., Ahmad, F. S., Allen, R. B., Altin, S. E., Auerbach, A. D., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.06.013 · Cited by 257
Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update
Veitch, A., Radaelli, F., Alikhan, R., Dumonceau, J., Eaton, D., Jerrome, J., Lester, W., Nylander, D. L., Thoufeeq, M., Vanbiervliet, G., et al. (2021) · Gut · doi:10.1136/gutjnl-2021-325184 · Cited by 212
Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery
Spyropoulos, A. C., Al-Badri, A., Sherwood, M. W., & Douketis, J. D. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13305 · Cited by 210
2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation
Chiang, C., Okumura, K., Zhang, S., Chao, T., Siu, C., Lim, T. W., Saxena, A., Takahashi, Y., & Teo, W. S. (2017) · Journal of Arrhythmia · doi:10.1016/j.joa.2017.05.004 · Cited by 200
“The BRIDGE trial has shown that in VKA-treated patients, bridging with LMWH has no benefit regarding thromboembolism but is instead an inferior strategy, since it can lead to a higher incidence of major bleeding [224].”
Perioperative Neurological Evaluation and Management to Lower the Risk of Acute Stroke in Patients Undergoing Noncardiac, Nonneurological Surgery: A Scientific Statement From the American Heart Association/American Stroke Association
Benesch, C. G., Glance, L. G., Derdeyn, C. P., Fleisher, L. A., Holloway, R. G., Messe, S. R., Sells, C. M. M., Nelson, M. T., Power, M., & Welch, B. G. (2021) · Circulation · doi:10.1161/cir.0000000000000968 · Cited by 190
American College of Gastroenterology-Canadian Association of Gastroenterology Clinical Practice Guideline: Management of Anticoagulants and Antiplatelets During Acute Gastrointestinal Bleeding and the Periendoscopic Period
Abraham, N. S., Barkun, A. N., Sauer, B. G., Douketis, J. D., Laine, L., Noseworthy, P. A., Telford, J. J., & Leontiadis, G. I. (2022) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001627 · Cited by 190
“A few weeks after the final panel voting meeting, the PERIOP-2 trial was published as full text showing similar results to the BRIDGE trial (72).”
Influential
Prediction model of bleeding after endoscopic submucosal dissection for early gastric cancer: BEST-J score
Hatta, W., Tsuji, Y., Yoshio, T., Kakushima, N., Hoteya, S., Doyama, H., Nagami, Y., Hikichi, T., Kobayashi, M., Morita, Y., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-319926 · Cited by 175
Social determinants of atrial fibrillation
Essien, U. R., Kornej, J., Johnson, A. E., Schulson, L., Benjamin, E. J., & Magnani, J. W. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00561-0 · Cited by 169
Interventional Spine and Pain Procedures in Patients on Antiplatelet and Anticoagulant Medications (Second Edition)
Narouze, S., Benzon, H. T., Provenzano, D. A., Buvanendran, A., Andrés, J. A. D., Deer, T. R., Rauck, R. L., & Huntoon, M. A. (2017) · Regional Anesthesia & Pain Medicine · doi:10.1097/aap.0000000000000700 · Cited by 175
Guidance for the practical management of warfarin therapy in the treatment of venous thromboembolism
Witt, D. M., Clark, N. P., Kaatz, S., Schnurr, T., & Ansell, J. (2016) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-015-1319-y · Cited by 167
Perioperative Care of Patients at High Risk for Stroke during or after Non-Cardiac, Non-Neurologic Surgery
Mashour, G. A., Moore, L. E., Lele, A. V., Robicsek, S. A., & Gelb, A. W. (2014) · Journal of Neurosurgical Anesthesiology · doi:10.1097/ana.0000000000000087 · Cited by 161
Manejo perioperatorio y periprocedimiento del tratamiento antitrombótico: documento de consenso de SEC, SEDAR, SEACV, SECTCV, AEC, SECPRE, SEPD, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEPAR, SENEC, SEO, SEPA, SERVEI, SECOT y AEU
Vivas, D., Roldán, I., Ferrandis, R., Marín, F. R., Roldán, V., Tello‐Montoliu, A., Ruiz-Nodar, J. M., Gómez‐Doblas, J. J., Martı́n, A., Llau, J. V., et al. (2018) · Revista Española de Cardiología · doi:10.1016/j.recesp.2018.01.001 · Cited by 153
2018 Korean Guideline of Atrial Fibrillation Management
Joung, B., Lee, J., Lee, K. H., Kim, T., Choi, E., Lim, W., Kang, K., Uhm, J., Lim, H. E., Park, J., et al. (2018) · Korean Circulation Journal · doi:10.4070/kcj.2018.0339 · Cited by 157
Predictors of pre-procedural concentrations of direct oral anticoagulants: a prospective multicentre study
Godiér, A., Dincq, A.-S., Martin, A., Radu, A., Leblanc, I., Antona, M., Vasse, M., Golmard, J., Mullier, F., & Gouin‐Thibault, I. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx403 · Cited by 152
Scientific and Standardization Committee Communication: Guidance document on the periprocedural management of patients on chronic oral anticoagulant therapy: Recommendations for standardized reporting of procedural/surgical bleed risk and patient‐specific thromboembolic risk
Spyropoulos, A. C., Brohi, K., Caprini, J. A., Samama, C. M., Siegal, D. M., Tafur, A. J., Verhamme, P. B., & Douketis, J. D. (2019) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14598 · Cited by 147
American College of Surgeons’ Guidelines for the Perioperative Management of Antithrombotic Medication
Hornor, M. A., Duane, T. M., Ehlers, A. P., Jensen, E. H., Brown, P. S., Pohl, D., Costa, P., Ko, C. Y., & Laronga, C. (2018) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2018.08.183 · Cited by 143
2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation
Chiang, C., Wu, T.-J., Ueng, K.-C., Chao, T., Chang, K., Wang, C.-C., Lin, Y., Yin, W., Kuo, J., Lin, W., et al. (2016) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2016.10.005 · Cited by 138
Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update
Veitch, A., Radaelli, F., Alikhan, R., Dumonceau, J., Eaton, D., Jerrome, J., Lester, W., Nylander, D. L., Thoufeeq, M., Vanbiervliet, G., et al. (2021) · Endoscopy · doi:10.1055/a-1547-2282 · Cited by 136
“There are relatively few studies of the risks of haemorrhage for endoscopic procedures in patients who continue antithrombotic therapy, therefore much of the data underlying the risk levels for these procedures applies to the baseline risk of haemorrhage without antithrombotic therapy ( ▶ Table3 ).”
JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias
Ono, K., Iwasaki, Y., Akao, M., Ikeda, T., Ishii, K., Inden, Y., Kusano, K., Kobayashi, Y., Koretsune, Y., Sasano, T., et al. (2022) · Circulation Journal · doi:10.1253/circj.cj-20-1212 · Cited by 132
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a clinical consensus statement of the ESC working group on pulmonary circulation and right ventricular function
Lang, I. M., Andreassen, A. K., Andersen, A., Bouvaist, H., Coghlan, G., Subías, P. E., Jansa, P., Kopeć, G., Kurzyna, M., Matsubara, H., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad413 · Cited by 123
Guidelines for Diagnostic Flexible Bronchoscopy in Adults: Joint Indian Chest Society/National College of Chest Physicians (I)/Indian Association for Bronchology Recommendations
Mohan, A., Madan, K., Hadda, V., Tiwari, P., Mittal, S., Guleria, R., Khilnani, G., Luhadia, S., Solanki, R., Gupta, K., et al. (2019) · Lung India · doi:10.4103/lungindia.lungindia_108_19 · Cited by 116
“Data from cardiovascular studies showed that warfarin interruption in atrial fibrillation increases the risk of thromboembolic events, and bridging therapy does not prevent such events; in fact, low molecular-weight heparin (LMWH) increases the risk of major perioperative bleeding.[56,57] In a recent meta-analysis of…”
Background
Anesthetic management of geriatric patients
Lim, B. G., & Lee, I. O. (2019) · Korean Journal of Anesthesiology · doi:10.4097/kja.19391 · Cited by 123
“In the majority of cases, perioperative bridging anticoagulation is no longer recommended when using novel oral anticoagulants and vitamin-K antagonists [64].”
Background
Bridging Anticoagulation
Rechenmacher, S. J., & Fang, J. C.-T. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.08.002 · Cited by 117
“(11), RE-LY (Randomized Evaluation of Long Term Anticoagulant Therapy With Dabigatran Etexilate) (28), and BRIDGE (4).”
BackgroundMethodInfluential
Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper
Gorog, D. A., Gue, Y. X., Chao, T., Fauchier, L., Ferreiro, J. L., Huber, K., Konstantinides, S., Lane, D. A., Marín, F. R., Oldgren, J., et al. (2022) · Thrombosis and Haemostasis · doi:10.1055/s-0042-1750385 · Cited by 116
2024 EACTS/EACTAIC Guidelines on patient blood management in adult cardiac surgery in collaboration with EBCP
Casselman, F. P. A., Lance, M. D., Ahmed, A. B., Ascari, A., Blanco-Morillo, J., Bolliger, D., Eid, M., Erdoes, G., Haumann, R. G., Jeppsson, A., et al. (2024) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezae352 · Cited by 138
A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery
Rossini, R., Tarantini, G., Musumeci, G., Masiero, G., Barbato, E., Calabrò, P., Capodanno, D., Leonardi, S., Lettino, M., Limbruno, U., et al. (2018) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2017.10.051 · Cited by 111
Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial
Kovacs, M. J., Wells, P. S., Anderson, D. R., Lazo‐Langner, A., Kearon, C., Bates, S. M., Blostein, M. D., Kahn, S. R., Schulman, S., Sabri, E., et al. (2021) · BMJ · doi:10.1136/bmj.n1205 · Cited by 111
Therapeutic endoscopy-related GI bleeding and thromboembolic events in patients using warfarin or direct oral anticoagulants: results from a large nationwide database analysis
Nagata, N., Yasunaga, H., Matsui, H., Fushimi, K., Watanabe, K., Akiyama, J., Uemura, N., & Niikura, R. (2017) · Gut · doi:10.1136/gutjnl-2017-313999 · Cited by 108
EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer
Falanga, A., Leader, A., Ambaglio, C., Bagoly, Z., Castaman, G., Elalamy, I., Lecumberri, R., Niessner, A., Pabinger, I., Szmit, S., et al. (2022) · HemaSphere · doi:10.1097/hs9.0000000000000750 · Cited by 106
Non-cardiac surgery in patients with coronary artery disease: risk evaluation and periprocedural management
Cao, D., Chandiramani, R., Capodanno, D., Berger, J. S., Levin, M. A., Hawn, M. T., Angiolillo, D. J., & Mehran, R. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0410-z · Cited by 106
Patient Blood Management
Spahn, D. R., Múñoz, M., Klein, A. A., Levy, J. H., & Zacharowski, K. D. (2020) · Anesthesiology · doi:10.1097/aln.0000000000003198 · Cited by 98
2024 EACTS Guidelines on perioperative medication in adult cardiac surgery
Jeppsson, A., (Sweden), (.-C., Rocca, B., (Italy), (.-C., Hansson, E. C., (Sweden), Guðbjartsson, T., (Iceland), James, S. K., (Sweden), et al. (2024) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezae355 · Cited by 114
SCAI expert consensus statement: 2016 best practices in the cardiac catheterization laboratory: (Endorsed by the cardiological society of india, and sociedad Latino Americana de Cardiologia intervencionista; Affirmation of value by the Canadian Association of interventional cardiology–Association canadienne de cardiologie d'intervention)*
Naidu, S. S., Aronow, H. D., Box, L. C., Duffy, P. L., Kolansky, D. M., Kupfer, J. M., Latif, F., Mulukutla, S. R., Rao, S. V., Swaminathan, R. V., et al. (2016) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.26551 · Cited by 96
The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and Rationale
Douketis, J. D., Spyropoulos, A. C., Anderson, J., Arnold, D. M., Bates, S. M., Blostein, M. D., Carrier, M., Caprini, J. A., Clark, N. P., Coppens, M., et al. (2017) · Thrombosis and Haemostasis · doi:10.1160/th17-08-0553 · Cited by 99
Bleeding after endoscopic submucosal dissection: Risk factors and preventive methods
Kataoka, Y., Tsuji, Y., Sakaguchi, Y., Minatsuki, C., Asada‐Hirayama, I., Niimi, K., Ono, S., Kodashima, S., Yamamichi, N., Fujishiro, M., et al. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i26.5927 · Cited by 95
2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias
Cronin, E. M., Bogun, F. M., Maury, P., Peichl, P., Chen, M., Namboodiri, N., Aguinaga, L., Leite, L. R., Al‐Khatib, S. M., Anter, E., et al. (2020) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-019-00663-3 · Cited by 95
Reimagining Anticoagulation Clinics in the Era of Direct Oral Anticoagulants
Barnes, G. D., Nallamothu, B. K., Sales, A. E., & Froehlich, J. B. (2016) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.115.002366 · Cited by 90
Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
Angiolillo, D. J., Goodman, S. G., Bhatt, D. L., Eikelboom, J. W., Price, M. J., Moliterno, D. J., Cannon, C. P., Tanguay, J., Granger, C. B., Mauri, L., et al. (2016) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.116.004395 · Cited by 90
“tion of thromboembolism and decreased the occurrence of major bleeding.(156)”
Background
Management of direct oral anticoagulants in patients undergoing elective surgeries and invasive procedures: Updated guidelines from the French Working Group on Perioperative Hemostasis (GIHP) – September 2015
Albaladejo, P., Bonhomme, F., Blais, N., Collet, J., Faraoni, D., Fontana, P., Godiér, A., Llau, J. V., Longrois, D., Marret, E., et al. (2016) · Anaesthesia Critical Care & Pain Medicine · doi:10.1016/j.accpm.2016.09.002 · Cited by 89
Practice Patterns and Outcomes Associated With Use of Anticoagulation Among Patients With Atrial Fibrillation During Sepsis
Walkey, A. J., Quinn, E. K., Winter, M. R., McManus, D. D., & Benjamin, E. J. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.2181 · Cited by 88
Guideline of guidelines: thromboprophylaxis for urological surgery
Violette, P. D., Cartwright, R., Briel, M., Tikkinen, K. A. O., & Guyatt, G. H. (2016) · British Journal of Urology · doi:10.1111/bju.13496 · Cited by 87
Perioperative Guidelines on Antiplatelet and Anticoagulant Agents: 2022 Update
Moster, M., & Bolliger, D. (2022) · Current anesthesiology reports · doi:10.1007/s40140-021-00511-z · Cited by 87
Perioperative management of anticoagulant and antiplatelet therapy
Tafur, A. J., & Douketis, J. D. (2017) · Heart · doi:10.1136/heartjnl-2016-310581 · Cited by 89
Initial management for acute lower gastrointestinal bleeding
Aoki, T., Hirata, Y., Yamada, A., & Koike, K. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i1.69 · Cited by 86
Holmium Laser Enucleation of the Prostate in Patients Requiring Anticoagulation
Tayeb, M. M. E., Jacob, J. M., Bhojani, N., Bammerlin, E., & Lingeman, J. E. (2016) · Journal of Endourology · doi:10.1089/end.2016.0070 · Cited by 85

Authors: Douketis, J. D., Spyropoulos, A. C., Kaatz, S., Becker, R. C., Caprini, J. A., Dunn, A. S., Garcia, D. A., Jacobson, A., Jaffer, A. K., Kong, D. F., Schulman, S., Turpie, A. G. G., Hasselblad, V., & Ortel, T. L.
Affiliations: Rush University Medical Center (US)
Northwell Health (US)
Hurley Medical Center (US)
University of Cincinnati (US)
Endeavor Health (US)
University of Washington Medical Center (US)
Duke Medical Center (US)
McMaster University (CA)
ORCID: Douketis, James D.
Spyropoulos, Alex C.
Kaatz, Scott
Becker, Richard C.
Dunn, Andrew S.
Garcia, David A.
Jaffer, Amir K.
Schulman, Sam
Ortel, Thomas L.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2015-08-27
Volume: 373
Issue: 9
Pages: 823-833
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa1501035
PMC: PMC4931686
OpenAlex: W1837600385
Cited by: 1,184
References: 46
Citations by year: 2026: 63 · 2025: 64 · 2024: 79 · 2023: 70 · 2022: 87 · 2021: 115 · 2020: 132 · 2019: 117 · 2018: 134 · 2017: 141 · 2016: 141 · 2015: 35
FWCI: 109.42
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health
National Heart, Lung, and Blood Institute (U01HL086755, U01HL087229)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Keywords: atrial fibrillation, low molecular weight heparin, dalteparin, warfarin interruption, arterial thromboembolism, major bleeding, elective surgery, non-inferiority, stroke prevention, systemic embolism, transient ischemic attack, postoperative bleeding risk
MeSH terms: Adult, Anticoagulants, Atrial Fibrillation, Double-Blind Method, Female, Hemorrhage, Heparin, Low-Molecular-Weight, Humans, Male, Postoperative Complications, Thromboembolism, Warfarin, Elective Surgical Procedures, Perioperative Period

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks